Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Desmodium adscendens extract** is a botanical preparation derived from the leaves of the plant *Desmodium adscendens*, traditionally used in West Africa, South America, and increasingly in Europe for medicinal purposes. It is primarily indicated as a hepatoprotective agent for liver health, especially during medication or chemotherapy, but is also noted for antispasmodic, antihistamine, antioxidant, antimicrobial, anti-inflammatory, immune-stimulating, and neurological effects[2][3]. The extract’s pharmacological activity is attributed to saponosides (purifying, diuretic), flavonoids (anti-inflammatory, immune stimulatory, antioxidant), phenylethylamines, indole-3-alkylamines, triterpenoid saponins (soyasaponin I and III, dehydrosoyasaponin I), and others[3]. Its mechanism of action includes interaction with cytochrome P450 enzymes in the liver (notably CYP2B1/2B2 and CYP2E), which can lead to changes in drug metabolism and potential herb-drug interactions[1][3]. It is usually administered orally, in capsule or ampoule form, and is marketed as a standardized extract in saponosides to ensure consistency of active ingredient levels[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on desmodium adscendens extract.